Wednesday, September 3rd, 2014 - Wholesale Investor

SYDNEY, AUSTRALIA - Wholesale Investor, Australia’s leading private investment platform, will host the Sydney Capital Showcase Event 2014 in Sydney on Friday September 5.

Wholesale Investor is Australia’s largest private investment platform directly connecting high net worth and professional investors with Private, Pre-IPO and Small Cap ASX Listed investment opportunities that are often not available on the open market.

Presented in association with principal support partners PwC, DLA Piper and NZTE the Showcase will provide up to 150 high net worth and professional investors with the opportunity to gain direct access to 9 high growth Private, Pre-IPO and Listed Companies in Life Sciences, Healthcare, Cleantech, Internet, Technology, Financial Services, Telecommunications and Agriculture sectors in one afternoon. You will be able to hear live presentations, and then speak one on one with the CEOs about their business, gain information straight from the source and discover unseen opportunities.

"The last 12 months have been exciting times for Private, Pre-IPO, and emerging growth companies, as investors, fund managers and Family Offices have become more active in their support and investment into innovative growth companies. In this period Wholesale Investor has Showcased over 120 companies and over $500million in capital raising offers throughout Australia, New Zealand and Singapore, to over 3000 investors at Investor events. It highlights the demand and opportunity for Australian and New Zealand Innovation.” says Steve Torso, Wholesale Investor's Managing Director.
 

3 examples of the companies being featured are:
 

Breathe Easy Therapeutics Ltd - Ground-breaking drug therapy developer combating Cystic Fibrosis with clinical efficacy study approval

Breathe Easy Therapeutics is developing Citramel™, an inhaled drug therapy for Cystic Fibrosis (“CF”), a chronic genetic illness affecting the lungs of approximately 75,000 children and adults worldwide. It is approved for use in a clinical efficacy study, which is ready to start, pending funding. Citramel is believed to work by breaking down the biofilms in the thick, sticky mucus, which clogs the lungs and causes recurrent infection and inflammation. The trial is therefore expected to show that Citramel is effective in improving lung function.          

Citramel is also expected to enhance effectiveness of other CF therapies such as antibiotics as the breakdown of this thick mucus is expected to help the entry and effectiveness of antibiotics and elements of the immune system. Citramel has already been used on compassionate grounds with effective results.

Kahne Ltd - Revolutionary NZ agritech company providing a world first in vivo rumen continuous monitoring solution via web-based software apps to optimise herd performance in dairy and beef cattle

Producers in highly competitive global markets are increasingly looking for ways to improve the productivity, health, and sustainability of their operations. The most important indicator of a cow’s productivity and health rests inside the animal’s rumen, where fermentation occurs and feed is converted to energy for milk production and muscle mass development.            

Kahne Ltd is a New Zealand agritech company that has developed the world’s first in vivo (in the living organism) rumen continuous monitoring solution to drive health and performance improvements in dairy and beef cattle. Kahne is focused on delivering these improvements with its sensor-enabled solutions that allow the health status of individual livestock to be continuously monitored, automatically analysed and reported via web-based software apps.

Cure Brain Cancer Foundation - Australia's largest dedicated funder of brain cancer research - early adopters of disruptive funding models to commercialise research projects

Cure Brain Cancer Foundation is the largest dedicated funder of brain cancer research in Australia. Partnering with the research community, we are steering the national agenda for brain cancer research. The foundation was a founding partner of a global brain cancer alliance and held an international meeting earlier in 2014 with the world’s leading brain cancer researchers and stakeholders.

Cure Brain Cancer Foundation is looking to expand current funding models used by NFPs in Australia to fund projects and consider themselves early adopters in this disruptive model to commercialise research projects.
 

Entry is free. Lunch will be provided. 


EVENT DETAILS:

Date: Friday 5 September 2014
Time: 12.00pm-2.00pm
Venue: Level 47, MLC Centre, 19 Martin Place, Sydney NSW
Catering:  Lunch and drinks will be supplied before the event
Cost: This is a free event for investors, stockbrokers and fund managers
 

To register for the Sydney Capital Showcase September Event 2014, please go to: 

http://www.wholesaleinvestor.com.au/events/sydney-showcase-event-september-2014-2/
 

PRESENTING COMPANIES:

MBD Energy Ltd
Investors Central Ltd
Leaf Resources Ltd

Lypanosys Ltd
Breathe Easy Therapeutics Ltd
Kahne Ltd
Fusion Payments Ltd
Global Wealth Partners Ltd
Cure Brain Cancer Foundation

 

MBD Energy Ltd

MBD provides environmental waste management solutions with an emphasis on the clean-up of industrially contaminated waste water to comply with government mandated waste water licensing controls in jurisdictions across the Asia Pacific region.

Investors Central Ltd

Investors Central is high growth automotive lending funder with fixed interest returns. Investors Central has experienced a 53% increase in the last 12 months.

Leaf Resources Ltd (ASX:LER)

Leaf Reources is an award-winning, green and sustainable platform technology company that can help turn waste plant material into biofuels, bioplastics and green chemicals with a green, sustainable, economical process.

Lypanosys Ltd

Lypanosys is a drug development company, with the company’s lead compound, LYP-010, being a naturally derived, fatty acid based product, that is being developed as a safe, oral (capsule and oral suspension) product for the treatment of Eczema.

Breathe Easy Therapeutics Ltd

Breathe Easy Therapeutics is developing Citramel™, an inhaled drug therapy for Cystic Fibrosis (“CF”), a chronic genetic illness affecting the lungs of approximately 75,000 children and adults worldwide. It is approved for use in a clinical efficacy study, which is ready to start, pending funding.

Kahne Ltd

Kahne Ltd is a New Zealand agritech company that has developed the world’s first in vivo (in the living organism) rumen continuous monitoring solution to drive health and performance improvements in dairy and beef cattle.

Fusion Payments Ltd

Fusion Payments is a cloud-based software services company providing an integrated suite of mobile banking, payment, recharge and security solutions to Mobile Network Operators (MNO). With over 20m users and blue-chip partnerships (Visa and ePay), the company has offices and clients in Australia, Asia and expanding into the LatAm and the Middle East.

Global Wealth Partners Ltd

IPO Offering- GWP is a globally diversified fund with leading alternative investment managers with proven track records of protecting and growing capital over the medium-to-long term in mixed market conditions. GWP's board members include David Koch, Warwick Negus and Andrew Martin.

Cure Brain Cancer Foundation

Cure Brain Cancer Foundation is the largest dedicated funder of brain cancer research in Australia. Partnering with the research community, we are steering the national agenda for brain cancer research. Cure Brain Cancer Foundation is looking to expand current funding models and consider themselves early adopters in this disruptive model to commercialise research projects.

Contact Profile

Wholesale Investor


Wholesale Investor is Australia's leading private investment platform showcasing Private, Pre-IPO and Life Sciences ASX Listed Opportunities to over 8,600 High Net Worth, Professional and International investors.
Steve Torso
P: Ph: 1300 597 595
W: www.wholesaleinvestor.com.au/

Keywords

capital, capital raising, showcase, investors, money raising, lifescience, technology, cleantech, funds, fund manager, healthcare, finance, high net worth, wholesale investor, presentations

Categories

Newsrooms

Sharing

More Formats